These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12916001)

  • 1. Identification of a novel variant in the phosphoenolpyruvate carboxykinase gene promoter in Japanese patients with type 2 diabetes.
    Horikawa Y; Yamasaki T; Nakajima H; Shingu R; Yoshiuchi I; Miyagawa J; Namba M; Hanafusa T; Matsuzawa Y
    Horm Metab Res; 2003 May; 35(5):308-12. PubMed ID: 12916001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of insulin, cAMP, and dexamethasone on phosphoenolpyruvate carboxykinase gene promoter in vitro].
    Feng K; Wang H; Sun Q; Xiao XH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Dec; 26(6):639-42. PubMed ID: 15663223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a single nucleotide polymorphism showing no insulin-mediated suppression of the promoter activity in the human insulin receptor substrate 2 gene.
    Iwamoto K; Mori H; Okazawa H; Hashiramoto M; Kasuga M
    Diabetologia; 2002 Aug; 45(8):1182-95. PubMed ID: 12189449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation by glucagon (cAMP) and insulin of the promoter of the human phosphoenolpyruvate carboxykinase gene (cytosolic) in cultured rat hepatocytes and in human hepatoblastoma cells.
    Rucktäschel AK; Granner DK; Christ B
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):211-7. PubMed ID: 11062075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between sorbitol dehydrogenase gene polymorphisms and type 2 diabetic retinopathy.
    Szaflik JP; Majsterek I; Kowalski M; Rusin P; Sobczuk A; Borucka AI; Szaflik J; Blasiak J
    Exp Eye Res; 2008 Apr; 86(4):647-52. PubMed ID: 18289528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Examination of the phosphoenolpyruvate carboxykinase gene promoter in patients with noninsulin-dependent diabetes mellitus.
    Ludwig DS; Vidal-Puig A; O'Brien RM; Printz RL; Granner DK; Moller DE; Flier JS
    J Clin Endocrinol Metab; 1996 Feb; 81(2):503-6. PubMed ID: 8636258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene polymorphisms and antigen levels of matrix metalloproteinase-1 in type 2 diabetes mellitus coexisting with coronary heart disease.
    Drzewoski J; Sliwińska A; Przybyłowska K; Sliwiński T; Kasznicki J; Zurawska-Klis M; Kosmalski M; Majsterek I
    Kardiol Pol; 2008 Oct; 66(10):1042-8; discussion 1049. PubMed ID: 19006025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1484insG polymorphism of the PTPN1 gene is associated with insulin resistance in an Iranian population.
    Meshkani R; Taghikhani M; Mosapour A; Larijani B; Khatami S; Khoshbin E; Ahmadvand D; Saeidi P; Maleki A; Yavari K; Nasoohi N; Adeli K
    Arch Med Res; 2007 Jul; 38(5):556-62. PubMed ID: 17560463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale study of the -232C > G polymorphism of PCK1 in Type 2 diabetes.
    Wegner L; Andersen G; Albrechtsen A; Sparsø T; Glümer C; Borch-Johnsen K; Jørgensen T; Hansen T; Pedersen O
    Diabet Med; 2006 Oct; 23(10):1140-4. PubMed ID: 16978381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction and identification of recombinant firefly luciferase reporter plasmid pGL2-PEPCK-Luc].
    Feng K; Wang H; Sun Q; Xiao XH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Oct; 26(5):562-5. PubMed ID: 15562773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of a functional inducible nitric oxide synthase promoter variant with complications in type 2 diabetes.
    Morris BJ; Markus A; Glenn CL; Adams DJ; Colagiuri S; Wang L
    J Mol Med (Berl); 2002 Feb; 80(2):96-104. PubMed ID: 11907646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Merit of physical exercise to reverse the higher gene expression of hepatic phosphoenolpyruvate carboxykinase in obese Zucker rats.
    Chang SP; Chen YH; Chang WC; Liu IM; Cheng JT
    Life Sci; 2006 Jun; 79(3):240-6. PubMed ID: 16458327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association of the hepatic lipase gene -250G/A promoter polymorphism with the susceptibility to type 2 diabetes mellitus combining with coronary heart disease].
    Wei M; Lu YS; Li PP
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):219-22. PubMed ID: 19350521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Association of mitochondrial DNA variation with type 2 diabetes mellitus].
    Tang DL; Zhou X; Zhou KY; Li X; Zhao L; Liu F; Zheng F; Liu SM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):636-40. PubMed ID: 16331560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel -192c/g mutation in the proximal P2 promoter of the hepatocyte nuclear factor-4 alpha gene (HNF4A) associates with late-onset diabetes.
    Ek J; Hansen SP; Lajer M; Nicot C; Boesgaard TW; Pruhova S; Johansen A; Albrechtsen A; Yderstraede K; Lauenborg J; Parrizas M; Boj SF; Jørgensen T; Borch-Johnsen K; Damm P; Ferrer J; Lebl J; Pedersen O; Hansen T
    Diabetes; 2006 Jun; 55(6):1869-73. PubMed ID: 16731855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of polymorphism of the GLUT2 promoter in NIDDM patients and its functional consequence to the promoter activity.
    Cha JY; Kim HS; Kim HI; Im SS; Kim SY; Kim JW; Yeh BI; Ahn YH
    Ann Clin Lab Sci; 2002; 32(2):114-22. PubMed ID: 12017192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The relationship between the variants in 5' upstream core promoter A(-6)G and A(-20)C of angiotensinogen gene and essential hypertension in Kazakans of Xinjiang].
    Li NF; Zhou L; Wu WD; Shi Y; Wang XL; Wang J; Li HJ; Zhang DL; Zu H; Ouyang WJ; Bu KL; Zhou KM; Cheng QY; Guli N; Zhu DH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Feb; 21(1):23-8. PubMed ID: 14767903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Pro387Leu variant of protein tyrosine phosphatase-1B is not associated with diabetes mellitus type 2 in a German population.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Intern Med; 2005 Mar; 257(3):272-80. PubMed ID: 15715684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of glucose-6-phosphatase gene expression by insulin and metformin.
    Mues C; Zhou J; Manolopoulos KN; Korsten P; Schmoll D; Klotz LO; Bornstein SR; Klein HH; Barthel A
    Horm Metab Res; 2009 Oct; 41(10):730-5. PubMed ID: 19579180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of phosphoenolpyruvate carboxykinase gene expression by metformin in cultured hepatocytes.
    Yuan L; Ziegler R; Hamann A
    Chin Med J (Engl); 2002 Dec; 115(12):1843-8. PubMed ID: 12622936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.